|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130.00 EUR | +0.85% |
|
+1.33% | +6.04% |
| 01-16 | MERCK KGAA : JP Morgan reiterates its Buy rating | ZD |
| 01-15 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Life Science | 7.53B | 9.05B | 10.44B | 9.36B | 9.01B | |||||
Total Assets | 20.14B | 21.92B | 24.2B | 23.48B | 25.21B | |||||
CAPEX | -704M | -506M | -801M | -953M | -858M | |||||
Gross Profit | 4.3B | 5.42B | 6.11B | 5.05B | 4.79B | |||||
EBITDA | 2.4B | 3.29B | 3.76B | 2.82B | 2.59B | |||||
D&A | 786M | 767M | 845M | 848M | 862M | |||||
Operating Income | 1.6B | 2.48B | 2.81B | 1.85B | 1.51B | |||||
Pharmaceutical Products | ||||||||||
Healthcare | 6.64B | 7.09B | 7.84B | 8.05B | 8.46B | |||||
Total Assets | 7.36B | 7.81B | 8.14B | 8.52B | 8.62B | |||||
CAPEX | -523M | -627M | -480M | -316M | -302M | |||||
Gross Profit | 5.03B | 5.37B | 5.92B | 6.02B | 6.25B | |||||
EBITDA | 2.27B | 2.15B | 2.48B | 2.54B | 3B | |||||
D&A | 324M | 315M | 303M | 299M | 331M | |||||
Operating Income | 1.8B | 1.82B | 1.9B | 2.22B | 2.48B | |||||
Semiconductor Manufacturing Machinery | ||||||||||
Electronics | 3.38B | 3.61B | 4.01B | 3.66B | 3.78B | |||||
Total Assets | 9.74B | 10.31B | 10.86B | 10.28B | 10.75B | |||||
CAPEX | -276M | -256M | -410M | -394M | -396M | |||||
Gross Profit | 1.41B | 1.57B | 1.72B | 1.36B | 1.48B | |||||
EBITDA | 1.02B | 1.13B | 1.19B | 913M | 970M | |||||
D&A | 561M | 528M | 545M | 526M | 498M | |||||
Operating Income | 240M | 509M | 572M | 248M | 360M | |||||
Corporate and Other | -18M | -62M | -61M | -77M | -91M | |||||
Total Assets | 4.56B | 5.33B | 5.34B | 6.22B | 6.99B | |||||
CAPEX | -59M | -31M | -117M | -145M | -146M | |||||
EBITDA | -495M | -465M | -579M | -397M | -482M | |||||
D&A | 84M | 103M | 105M | 109M | 116M | |||||
Operating Income | -658M | -632M | -801M | -713M | -702M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
USA | 4.64B | 5.25B | 6.3B | 5.91B | 5.65B | |||||
Total Assets | 19.52B | 20.81B | 22.51B | 21.35B | 23.06B | |||||
Other Europe | 3.55B | 4.03B | 4.52B | 4.4B | 4.5B | |||||
Total Assets | 2.81B | 2.84B | 2.93B | 3.12B | 3.42B | |||||
Asia-Pacific (Excluding China) | 3.74B | 4.09B | 4.48B | 4.18B | 4.14B | |||||
Total Assets | 1.37B | 1.38B | 1.41B | 1.3B | 1.35B | |||||
China | 2.22B | 2.55B | 2.82B | 2.48B | 2.58B | |||||
Total Assets | 406M | 452M | 480M | 491M | 520M | |||||
Latin America | 868M | 947M | 1.18B | 1.27B | 1.43B | |||||
Total Assets | 148M | 169M | 213M | 227M | 202M | |||||
Germany | 1.5B | 1.66B | 1.53B | 1.42B | 1.41B | |||||
Total Assets | 3.2B | 3.43B | 3.48B | 4B | 3.98B | |||||
Switzerland | 462M | 529M | 592M | 512M | 594M | |||||
Total Assets | 2.5B | 2.68B | 2.83B | 2.88B | 2.84B | |||||
Middle East and Africa (MEA) | 361M | 404M | 516M | 535M | 590M | |||||
Total Assets | 56M | 55M | 57M | 62M | 71M | |||||
North America (Excluding USA) | 191M | 225M | 294M | 287M | 263M | |||||
Total Assets | 17M | 17M | 16M | 16M | 15M |
- Stock Market
- Equities
- MRK Stock
- Financials Merck KGaA
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition